Literature DB >> 30428384

Tackling Ethical Challenges of Premature Delivery of Stem Cell-Based Therapies: ISSCR 2018 Annual Meeting Focus Session Report.

Jeremy Sugarman1, Roger A Barker2, Ian Kerridge3, Tamra Lysaght4, Graziella Pellegrini5, Douglas Sipp6, Claire Tanner7.   

Abstract

Clinical uses of unproven stem cell-based interventions abound, yet many patients may be harmed by receiving them, raising complex ethical, economic, and societal concerns. Regulators, scientists, clinicians, professional societies, and patient advocacy groups need to collaboratively articulate expectations related to the proper development and delivery of stem cell-based therapies.
Copyright © 2018.

Entities:  

Mesh：

Year:  2018        PMID： 30428384      PMCID： PMC7206334          DOI： 10.1016/j.stemcr.2018.10.020

Source DB:  PubMed          Journal:  Stem Cell Reports        ISSN： 2213-6711            Impact factor:   7.765


  17 in total

1.  The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research.

Authors:  Mm Horowitz
Journal:  Bone Marrow Transplant       Date:  2008-08       Impact factor: 5.483

2.  The structure of clinical translation: efficiency, information, and ethics.

Authors:  Jonathan Kimmelman; Alex John London
Journal:  Hastings Cent Rep       Date:  2015-01-27       Impact factor: 2.683

3.  Conditional approval: Japan lowers the bar for regenerative medicine products.

Authors:  Douglas Sipp
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

4.  Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism".

Authors:  Aaron L Berkowitz; Michael B Miller; Saad A Mir; Daniel Cagney; Vamsidhar Chavakula; Indira Guleria; Ayal Aizer; Keith L Ligon; John H Chi
Journal:  N Engl J Med       Date:  2016-06-22       Impact factor: 91.245

5.  ClinicalTrials.gov, stem cells and 'pay-to-participate' clinical studies.

Authors:  Leigh Turner
Journal:  Regen Med       Date:  2017-07-19       Impact factor: 3.806

6.  Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD.

Authors:  Ajay E Kuriyan; Thomas A Albini; Justin H Townsend; Marianeli Rodriguez; Hemang K Pandya; Robert E Leonard; M Brandon Parrott; Philip J Rosenfeld; Harry W Flynn; Jeffrey L Goldberg
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

7.  'No one here's helping me, what do you do?': addressing patient need for support and advice about stem cell treatments.

Authors:  Claire Tanner; Alan Petersen; Megan Munsie
Journal:  Regen Med       Date:  2017-11-08       Impact factor: 3.806

Review 8.  Marketing of unproven stem cell-based interventions: A call to action.

Authors:  Douglas Sipp; Timothy Caulfield; Jane Kaye; Jan Barfoot; Clare Blackburn; Sarah Chan; Michele De Luca; Alastair Kent; Christopher McCabe; Megan Munsie; Margaret Sleeboom-Faulkner; Jeremy Sugarman; Esther van Zimmeren; Amy Zarzeczny; John E J Rasko
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

9.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Authors:  Paolo Bianco; Xu Cao; Paul S Frenette; Jeremy J Mao; Pamela G Robey; Paul J Simmons; Cun-Yu Wang
Journal:  Nat Med       Date:  2013-01-07       Impact factor: 53.440

Review 10.  The Challenges of First-in-Human Stem Cell Clinical Trials: What Does This Mean for Ethics and Institutional Review Boards?

Authors:  Roger A Barker; Melissa K Carpenter; Stuart Forbes; Steven A Goldman; Catriona Jamieson; Charles E Murry; Jun Takahashi; Gordon Weir
Journal:  Stem Cell Reports       Date:  2018-05-08       Impact factor: 7.765
View more
  6 in total

1.  Identification of the risks in CAR T-cell therapy clinical trials in China: a Delphi study.

Authors:  Weijia Wu; Yan Huo; Xueying Ding; Yuhong Zhou; Shengying Gu; Yuan Gao
Journal:  Ther Adv Med Oncol       Date:  2020-10-17       Impact factor: 8.168

Review 2.  Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals.

Authors:  Eleonora Maurizi; Davide Adamo; Federica Maria Magrelli; Giulia Galaverni; Eustachio Attico; Alessia Merra; Maria Benedetta Rizzarda Maffezzoni; Lorena Losi; Vincenzo Giuseppe Genna; Virginia Sceberras; Graziella Pellegrini
Journal:  Front Bioeng Biotechnol       Date:  2021-03-25

3.  An Infodemic of Misinformation on Stem Cell Therapy Among the Population of Saudi Arabia: A Cross-Sectional Study.

Authors:  Doaa Aboalola; Heba Badraiq; Rawiah Alsiary; Samer Zakri; Neda Aboulola; Loay Haneef; Dalal Malibari; Moayad Baadhaim; Khaled Alsayegh
Journal:  Front Med (Lausanne)       Date:  2022-03-02

4.  Regulatory and policy tools to address unproven stem cell interventions in Canada: the need for action.

Authors:  Timothy Caulfield; Blake Murdoch
Journal:  BMC Med Ethics       Date:  2019-08-06       Impact factor: 2.652

Review 5.  Bringing Advanced Therapy Medicinal Products (ATMPs) for Parkinson's Disease to the Clinic: The Investigator's Perspective.

Authors:  Roger A Barker; Emma V Cutting; Danielle M Daft
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

6.  ISSCR's Guidelines for Stem Cell Research and Clinical Translation: Supporting development of safe and efficacious stem cell-based interventions.

Authors:  Leigh Turner
Journal:  Stem Cell Reports       Date:  2021-05-27       Impact factor: 7.765
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.